Do you think there will be a role for duvelisib in the treatment of relapsed/refractory chronic lymphocytic leukemia?

I believe this agent could find a home for therapy in CLL as it is given by itself provided that further efficacy is demonstrated in a population where it would be most likely used, ibrutinib resistant CLL. Additionally, incorporation into non-BTK inhibitor combinations would also be possible. Given...